Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

New tuberculosis technologies: challenges for retooling and scale-up.

Pai M, Palamountain KM.

Int J Tuberc Lung Dis. 2012 Oct;16(10):1281-90. doi: 10.5588/ijtld.12.0391. Review.

PMID:
23107630
2.

[Tuberculosis in Asia].

[No authors listed]

Kekkaku. 2002 Oct;77(10):693-7. Japanese.

PMID:
12440145
3.
4.

Retooling national TB control programmes (NTPs) with new diagnostics: the NTP perspective.

van Kampen SC, Ramsay AR, Anthony RM, Klatser PR.

PLoS One. 2010 Jul 19;5(7):e11649. doi: 10.1371/journal.pone.0011649.

5.

Translating tuberculosis research into global policies: the example of an international collaboration on diagnostics.

Ramsay A, Steingart KR, Cunningham J, Pai M.

Int J Tuberc Lung Dis. 2011 Oct;15(10):1283-93. doi: 10.5588/ijtld.11.0297.

PMID:
22283885
6.

New and improved tuberculosis diagnostics: evidence, policy, practice, and impact.

Pai M, Minion J, Steingart K, Ramsay A.

Curr Opin Pulm Med. 2010 May;16(3):271-84. doi: 10.1097/MCP.0b013e328338094f. Review.

PMID:
20224410
7.

Beyond accuracy: creating a comprehensive evidence base for TB diagnostic tools.

Mann G, Squire SB, Bissell K, Eliseev P, Du Toit E, Hesseling A, Nicol M, Detjen A, Kritski A.

Int J Tuberc Lung Dis. 2010 Dec;14(12):1518-24.

PMID:
21144235
8.
10.

Tuberculosis diagnostics: innovating to make an impact.

Ghanashyam B.

Expert Rev Anti Infect Ther. 2011 Apr;9(4):381-4. doi: 10.1586/eri.11.18.

PMID:
21504393
11.

Involving private health care providers in delivery of TB care: global strategy.

Uplekar M.

Tuberculosis (Edinb). 2003;83(1-3):156-64. Review.

PMID:
12758206
12.

Experience establishing tuberculosis laboratory capacity in a developing country setting.

Paramasivan CN, Lee E, Kao K, Mareka M, Kubendiran G, Kumar TA, Keshavjee S, Satti H, Alabi G, Raviglione M, Roscigno G.

Int J Tuberc Lung Dis. 2010 Jan;14(1):59-64.

PMID:
20003696
13.
14.

[Tuberculosis and its control--lessons from the past and future prospect].

Shimao T.

Kekkaku. 2005 Jun;80(6):481-9. Japanese.

PMID:
16130906
15.

[Reform of Japan's NTP and its technical perspectives].

Mori T.

Kekkaku. 2004 Oct;79(10):587-604. Review. Japanese.

PMID:
15631111
16.

TIME Impact - a new user-friendly tuberculosis (TB) model to inform TB policy decisions.

Houben RM, Lalli M, Sumner T, Hamilton M, Pedrazzoli D, Bonsu F, Hippner P, Pillay Y, Kimerling M, Ahmedov S, Pretorius C, White RG.

BMC Med. 2016 Mar 24;14:56. doi: 10.1186/s12916-016-0608-4.

17.

Strengthening cost-effectiveness analysis in Thailand through the establishment of the health intervention and technology assessment program.

Tantivess S, Teerawattananon Y, Mills A.

Pharmacoeconomics. 2009;27(11):931-45. doi: 10.2165/11314710-000000000-00000. Review.

PMID:
19888793
18.

The Global TB Drug Facility: innovative global procurement.

Kumaresan J, Smith I, Arnold V, Evans P.

Int J Tuberc Lung Dis. 2004 Jan;8(1):130-8. Review.

PMID:
14974756
19.

Public social policy development and implementation: a case study of the Ghana National Health Insurance scheme.

Agyepong IA, Adjei S.

Health Policy Plan. 2008 Mar;23(2):150-60. doi: 10.1093/heapol/czn002. Epub 2008 Feb 2.

PMID:
18245803
20.

Which new diagnostics for tuberculosis, and when?

Cobelens F, van den Hof S, Pai M, Squire SB, Ramsay A, Kimerling ME; Evidence for Scale-up Group.

J Infect Dis. 2012 May 15;205 Suppl 2:S191-8. doi: 10.1093/infdis/jis188. Epub 2012 Apr 3.

PMID:
22476716

Supplemental Content

Support Center